Elevance Health, Inc.

ELV 10-Q · Q1 2026
API behind this page

ELV Q1 2026 request

Playground key active
Request URL /api/financials?ticker=ELV&year=2026&quarter=1
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q1 2026 Q1 2025 YoY
Premiums Earned Net 41,024 40,887 +0.3%
Show Business Segments breakouts
Carelon Services · Operating Segments 779 1,500 -48.1%
Health Benefits · Operating Segments 40,452 39,588 +2.2%
Total Carelon · Operating Segments 779 1,500 -48.1%
Show Consolidation Items breakouts
Intersegment Elimination -207 -201 -3.0%
Revenue (Q) — — —
Show Product Lines breakouts
Product 6,225 5,809 +7.2%
Product · CarelonRx 6,225 5,809 +7.2%
Product · Total Carelon 6,225 5,809 +7.2%
Service fees 2,245 2,069 +8.5%
Service fees · Carelon Services 203 223 -9.0%
Service fees · CarelonRx 4 3 +33.3%
Service fees · Health Benefits 2,038 1,843 +10.6%
Service fees · Total Carelon 207 226 -8.4%
Operating Revenue 49,494 48,765 +1.5%
Show Business Segments breakouts
Carelon Services · Operating Segments 6,383 4,813 +32.6%
Carelon Services · Operating Segments 982 1,723 -43.0%
Carelon Services · Operating Segments 7,365 6,536 +12.7%
CarelonRx · Operating Segments 4,371 4,304 +1.6%
CarelonRx · Operating Segments 6,229 5,812 +7.2%
CarelonRx · Operating Segments 10,600 10,116 +4.8%
Corporate And Other · Operating Segments 4 165 -97.6%
Corporate And Other · Operating Segments 4 165 -97.6%
Health Benefits · Operating Segments 42,490 41,431 +2.6%
Health Benefits · Operating Segments 42,490 41,431 +2.6%
Reportable Segments 49,494 48,765 +1.5%
Total Carelon · Operating Segments 10,754 9,117 +18.0%
Total Carelon · Operating Segments 7,211 7,535 -4.3%
Total Carelon · Operating Segments 17,965 16,652 +7.9%
Show Consolidation Items breakouts
Intersegment Elimination -10,965 -9,483 -15.6%
Intersegment Elimination · Operating revenue - affiliated -10,758 -9,282 -15.9%
Intersegment Elimination · Operating revenue - unaffiliated -207 -201 -3.0%
Show Major Customers breakouts
Operating revenue - unaffiliated 49,494 48,765 +1.5%
Net Investment Income 765 590 +29.7%
Show Business Segments breakouts
Reportable Segments 765 590 +29.7%
Net Losses Gains On Financial Instruments -78 -464 +83.2%
Show Business Segments breakouts
Reportable Segments -78 -464 +83.2%
Revenue 50,181 48,891 +2.6%
Show Business Segments breakouts
Reportable Segments 50,181 48,891 +2.6%
Policyholder Benefits And Claims Incurred Net 35,615 35,312 +0.9%
Show Business Segments breakouts
Carelon Services · Operating Segments 6,085 5,319 +14.4%
Corporate And Other · Operating Segments 9 10 -10.0%
Health Benefits · Operating Segments 35,453 34,393 +3.1%
Total Carelon · Operating Segments 6,085 5,319 +14.4%
Show Legal Entity breakouts
Mosaic Health · Equity Method Investee 193 175 +10.3%
Show Consolidation Items breakouts
Intersegment Elimination -5,932 -4,410 -34.5%
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts
Liberty Dental 133 146 -8.9%
Cost of Revenue 5,463 4,983 +9.6%
Show Business Segments breakouts
CarelonRx · Operating Segments 9,830 9,284 +5.9%
Total Carelon · Operating Segments 9,830 9,284 +5.9%
Show Consolidation Items breakouts
Intersegment Elimination -4,367 -4,301 -1.5%
Selling, General & Administrative 6,330 5,300 +19.4%
Show Business Segments breakouts
Carelon Services · Operating Segments 810 726 +11.6%
CarelonRx · Operating Segments 188 230 -18.3%
Corporate And Other · Operating Segments 1,118 295 +279.0%
Health Benefits · Operating Segments 4,880 4,821 +1.2%
Total Carelon · Operating Segments 998 956 +4.4%
Show Consolidation Items breakouts
Intersegment Elimination -666 -772 +13.7%
Interest Expense 357 344 +3.8%
Show Business Segments breakouts
Reportable Segments 357 344 +3.8%
Amortization Of Intangible Assets 112 155 -27.7%
Show Business Segments breakouts
Reportable Segments 112 155 -27.7%
Benefits Losses And Expenses 47,877 46,094 +3.9%
Income Before Taxes 2,304 2,797 -17.6%
Show Business Segments breakouts
Reportable Segments 2,304 2,797 -17.6%
Income Tax Expense (Benefit) 544 613 -11.3%
Net Income 1,760 2,184 -19.4%
Show Equity Components breakouts
Noncontrolling Interest -4 1 -500.0%
Retained Earnings 1,764 2,183 -19.2%
Net Income Loss Attributable To Noncontrolling Interest 4 -1 +500.0%
Net Income 1,764 2,183 -19.2%
EPS (Basic) 8.03 9.64 -16.7%
EPS (Diluted) 8 9.61 -16.8%
Common Stock Dividends Per Share Declared 1.72 1.71 +0.6%
Operating Income 2,086 3,170 -34.2%
Show Business Segments breakouts
Carelon Services · Operating Segments 470 491 -4.3%
CarelonRx · Operating Segments 582 602 -3.3%
Corporate And Other · Operating Segments -1,123 -140 -702.1%
Health Benefits · Operating Segments 2,157 2,217 -2.7%
Reportable Segments 2,086 3,170 -34.2%
Total Carelon · Operating Segments 1,052 1,093 -3.8%
Comprehensive Income 1,474 2,419 -39.1%
Wtd Avg Shares (Basic) 219.8 226.4 -2.9%
Wtd Avg Shares (Diluted) 220.4 227.2 -3.0%
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 34,553 34,288 +0.8%

Balance Sheet

Balance Sheet
Metric Q1 2026 Q1 2025 YoY
Current Assets
Cash & Cash Equivalents 9,657 7,500 +28.8%
Available For Sale Securities Debt Securities Current 25,905 25,437 +1.8%
Equity Securities Fv Ni 1,511 715 +111.3%
Show Financial Instrument breakouts
Common equity securities 35 32 +9.4%
Exchange Traded Funds 1,428 621 +130.0%
Private Equity Funds 48 62 -22.6%
Premiums Receivable At Carrying Value 11,525 10,359 +11.3%
Self Funded Receivables Net 5,098 5,246 -2.8%
Other Receivables 6,167 6,576 -6.2%
Other Assets Current 7,169 5,288 +35.6%
Total Current Assets 67,032 61,121 +9.7%
Non-Current Assets
Property, Plant & Equipment 4,657 4,617 +0.9%
Goodwill 28,340 — —
Other Non-Current Assets 2,582 — —
Total Assets 125,827 119,717 +5.1%
Other Assets
Other Long Term Investments 11,009 — —
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level1 · Common equity securities 4 — —
Fair Value Inputs Level3 · Estimate Of Fair Value Fair Value Disclosure 765 — —
Show Financial Instrument breakouts
Common equity securities 4 — —
Show Legal Entity breakouts
Mosaic Health · Line Of Credit 282 — —
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts
Liberty Dental 145 — —
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure · Fair Value Measurements Nonrecurring 787 — —
Estimate Of Fair Value Fair Value Disclosure · Fair Value Measurements Recurring 765 — —
Show Investment Type breakouts
Other Long Term Investments 1,742 — —
Intangible Assets Net Excluding Goodwill 11,093 11,940 -7.1%
Current Liabilities
Liability For Claims And Claims Adjustment Expense 18,425 16,812 +9.6%
Other Policyholder Funds 3,857 3,796 +1.6%
Unearned Premiums 1,759 1,640 +7.3%
Accounts Payable And Accrued Liabilities Current 6,209 7,131 -12.9%
Short Term Borrowings 724 250 +189.6%
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level2 · Estimate Of Fair Value Fair Value Disclosure 724 250 +189.6%
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure · Fair Value Measurements Nonrecurring 724 250 +189.6%
Estimate Of Fair Value Fair Value Disclosure · Fair Value Measurements Recurring 724 250 +189.6%
Current Portion of Long-Term Debt 350 — —
Other Liabilities Current 13,985 11,426 +22.4%
Total Current Liabilities 45,309 42,698 +6.1%
Non-Current Liabilities
Available For Sale Securities Debt Securities Noncurrent 1,114 1,060 +5.1%
Long-Term Debt 30,768 — —
Deferred Tax Liabilities 1,786 2,121 -15.8%
Other Non-Current Liabilities 3,922 3,994 -1.8%
Total Liabilities 81,785 77,097 +6.1%
Long-Term Debt 31,118 — —
Show Debt Instrument breakouts
Senior Unsecured Notes · Senior Notes 31,093 29,728 +4.6%
Surplus Notes 25 25 0.0%
Other Liabilities
Preferred Stock Shares Authorized 100,000,000 — —
Stockholders' Equity
Common Stock 2 2 0.0%
Additional Paid-In Capital 8,845 8,866 -0.2%
Retained Earnings 35,796 34,546 +3.6%
Accumulated Other Comprehensive Income -741 -911 +18.7%
Total Stockholders' Equity 43,902 42,503 +3.3%
Minority Interest 140 117 +19.7%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 44,042 42,620 +3.3%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment Including Portion Attributable To Noncontrolling Interest -329 -404 +18.6%
Accumulated Net Investment Gain Loss Including Portion Attributable To Noncontrolling Interest -167 -289 +42.2%
Additional Paid In Capital 8,845 8,866 -0.2%
AOCI, Other Components [Member] -245 -218 -12.4%
Common Stock 2 2 0.0%
Noncontrolling Interest 140 117 +19.7%
Retained Earnings 35,796 34,546 +3.6%
Total Liabilities & Equity 125,827 119,717 +5.1%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q1 2026 YTD Q1 2025 YoY
Operating Activities
Income Loss From Equity Method Investments -305 -126 -142.1%
Depreciation Amortization And Accretion Net 354 373 -5.1%
Deferred Income Taxes -274 -174 -57.5%
Asset Impairment Charges 4 — —
Stock-Based Compensation 55 81 -32.1%
Increase Decrease In Receivables -1,174 -3,174 +63.0%
Increase Decrease In Other Operating Assets -1,552 -647 -139.9%
Increase Decrease In Insurance Liabilities 1,590 600 +165.0%
Increase Decrease In Deferred Revenue 266 132 +101.5%
Increase Decrease In Accounts Payable And Other Operating Liabilities 2,886 952 +203.2%
Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable 644 357 +80.4%
Net Cash from Operations 4,332 1,017 +326.0%
Investing Activities
Payments To Acquire Investments -4,735 -3,964 -19.5%
Proceedsfromsaleofequityandfixedmaturitysecurities 3,094 4,150 -25.4%
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 552 424 +30.2%
Increase Decrease In Collateral Held Under Securities Lending -313 -290 -7.9%
Payments To Acquire Businesses Net Of Cash Acquired 5 4 +25.0%
Capital Expenditures -235 -196 -19.9%
Other Investing Activities -10 -25 +60.0%
Net Cash from Investing -1,642 103 -1694.2%
Financing Activities
Repayments Of Long Term Debt -750 -1,250 +40.0%
Proceeds From Short Term Debt 724 — —
Repayments Of Short Term Debt -150 -115 -30.4%
Increase Decrease In Securities Lending Payable 313 290 +7.9%
Increase Decrease In Outstanding Checks Financing Activities -1,152 546 -311.0%
Share Repurchases -1,124 -880 -27.7%
Payments Of Dividends -376 -386 +2.6%
Proceeds From Stock Options Exercised 37 23 +60.9%
Tax Withholding for Share Compensation -34 -123 +72.4%
Proceeds From Payments For Other Financing Activities -3 -14 +78.6%
Net Cash from Financing -2,515 -1,909 -31.7%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -9 1 -1000.0%
Net Change in Cash 166 -788 +121.1%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 9,657 7,500 +28.8%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key